1,494 8% EBITDA Bio-Based Product Business4/ 113 179 59 -48% -67% 259 238 -8% EBITDA Resource Business5/ 59 133 93 58% -30% 81 226 181% EBITDA Others 6/ (25) (25) (12) 54% 53% (25) (37) -48% Profit
innovative knowledge, creative thinking, and innovative change. A total of 48 staff members from 16 departments (13 teams) participated in the event this year with qualified experts as the judges giving the
innovative knowledge, creative thinking, and innovative change. A total of 48 staff members from 16 departments (13 teams) participated in the event this year with qualified experts as the judges giving the
Central Pattana Public Company Limited (“The Company” or “CPN”) in 2Q19 shows total revenue of THB 9,197 mn, an increase of 0.7% and net profit stood at THB 2,470 mn, a decrease of 15.9% from the same
YoY (%) (Restated) Operating revenue 624 852 36.5% Cost of sales 256 356 39.1% Gross profit 368 496 34.8% EBITDA 443 352 -20.7% Interest expenses 5 23 401.9% NPAT from operation (excl. NCI) 187 192 2.8
YoY % Revenues from sales and services . . . .% . . .% . . . .% Gross profit from sales and services . . (.) (.%) . . .% . . . .% Other income . . . .% . . .% . . . .% Selling expenses
Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A) Page 1 of 16 Executive Summary CPN’s total revenue and net profit continues to grow according to its business plan
Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A) Page 1 of 16 Executive Summary CPN’s total revenue and net profit continues to grow according to its business plan
system. The performance of Central Pattana Public Company Limited (“The Company” or “CPN”) in 3Q19 shows total revenue of THB 9,413 mn, an increase of 2.1% and net profit stood at THB 2,816 mn, a decrease
DCON PRODUCTS PUBLIC Co.,Ltd. and Subsidiaries Company Management’s Discussion and Analysis (MD&A) For the Year 2019 1. Revenue,Gross Profit & Net Profit Unit :M.Bht Year 2019 Year 2018 Year 2017 1